Congressional interest in the development of bioterrorism countermeasures remains strong, even after passage of legislation establishing Project BioShield.During the 109th Congress, several bills were introduced (although not enacted),including S. 3, the Protecting America in the War on Terror Act, S. 975, the Project Bioshield II Act, and S. 1873, the Biodefense and Pandemic Vaccine and DrugDevelopment Act, that would have generated additional incentives for the creation of new technologies to counteract potential biological threats. These bills proposed reforms to current policies and practices associated with intellectual property,particularly patents, and the marketing of pharmaceuticals and related products…
Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security
- April 8, 2011
- | Filed under North America, Report, and 2001-2025
